CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823929248
- Phone
- 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-22 | Schmid John P. Director | Purchase | +9,156 | $3.62 | $33K | 9,156 |
| 2024-01-02 | Burgess Julie Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2024-01-02 | Jeffries Sean Chief Operating Officer | Grant or award · Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2023-12-01 | LAPPE RODNEY W Director | Grant or award · Stock Option (right to buy) | +69,186 | 69,186 | ||
| 2023-12-01 | Ansari Aseem Z. 10% owner | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-09-29 | LAPPE RODNEY W Director | Purchase | +21,000 | $2.35 | $49K | 133,024 |
| 2023-09-01 | Shah Pratik President, CEO and Chairperson | Grant or award · Stock Option (right to buy) | +1,050,000 | 1,050,000 | ||
| 2023-09-01 | Shah Pratik President, CEO and Chairperson | Grant or award · Stock Option (right to buy) | +525,000 | 525,000 | ||
| 2023-09-01 | Shah Pratik President, CEO and Chairperson | Grant or award · Stock Option (right to buy) | +525,000 | 525,000 | ||
| 2023-08-29 | Prasad Deepa Director | Purchase | +12,000 | $2.31 | $28K | 23,806 |
| 2023-08-29 | William Arsani Director | Purchase | +1,960,000 | $2.44 | $4.8M | 3,000,000 |
| 2023-08-28 | William Arsani Director | Purchase | +275,000 | $2.15 | $591K | 1,040,000 |
| 2023-05-31 | George Simeon Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-05-31 | Prasad Deepa Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-05-31 | Xu Stella Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-05-31 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-05-31 | William Arsani Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-05-31 | Berger Heather A. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-05-31 | LAPPE RODNEY W Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2023-02-01 | Burgess Julie Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 |
Page 3 of 7 · 135 trades